PTS Diagnostics specializes in point-of-care diagnostic products that focus on managing chronic diseases, particularly diabetes and heart disease. Their flagship products include the A1CNow system, which allows healthcare professionals and home users to obtain accurate A1C results quickly through a simple fingerstick method. This system facilitates immediate communication between clinicians and patients regarding diabetes management. Additionally, the CardioChek analyzers provide rapid and cost-effective lipid testing, delivering results in as little as 90 seconds, utilizing technology comparable to that found in clinical laboratories. The CardioChek family also includes PTS Panels test strips and a MEMo Chip, which enhance testing flexibility and maintain stability at room temperature.

The company emphasizes the importance of rapid and accurate testing in improving healthcare outcomes, aligning with modern healthcare models that prioritize efficiency. PTS Diagnostics is committed to empowering healthcare professionals with the necessary tools and information to enhance patient care. Their leadership team comprises experts in the medical device field, ensuring that their products meet the needs of both healthcare providers and patients. Through innovative technologies and a focus on chronic disease management, PTS Diagnostics aims to make a significant impact on public health.

United States

We are the makers of the CardioChek and A1CNow point-of-care test systems. Our aim is to help healthcare providers close gaps in care with fast, accurate testing for cardiovascular disease and diabetes risk factors. 

CardioChek Plus provides full lipid panel and glucose results in as little as 90 seconds. A1CNow provides A1C results in 5 minutes. Both systems are portable and easy to use, making them ideal for nearly any healthcare setting. 

The company’s name represents the three pillars upon which it has built its success: People, Technology, and Service. 



PTS Diagnostics

Company Details